Neurosarcoidosis Presenting WIth Panhypopituitarism
Document Type
Conference Proceeding
Publication Date
10-2023
Publication Title
Journal of the Endocrine Society
Abstract
Introduction: Neurosarcoidosis is estimated to occur in approximately 5-15% patients with sarcoidosis. Pituitary involvement may be present in up to 5% of those cases and can manifest as hypothalamus, adenohypophysis dysfunction or arginine vasopressin deficiency (AVP-D) in isolated fashion or variedly combined. Clinical case: 32 year old male presented with chief complaint of worsening bilateral lower extremity weakness, urinary incontinence, polyuria and polydipsia. 9 months prior to admission the patient was diagnosed with neurosarcoidosis. At that time brain MRI showed diffuse leptomeningeal enhancement, chest CT showed hilar lymphadenopathy, lumbar puncture with CSF analysis showed protein 227 mg/dl (N13.2), urine osmolality of 72 mOsmol/kg, blood osmolality of 297 mOsmol/kg (N
Volume
7
Issue
Suppl 1
First Page
A724
Recommended Citation
Niedzialkowska EM, Blazin T, Strubchevska K, Kozyk M, Saini N. Neurosarcoidosis presenting with panhypopituiarism. J Endocr Soc. 2023 Oct;7(Suppl 1):A724. doi:10.1210/jendso/bvad114.1357
DOI
10.1210/jendso/bvad114.1357
Comments
Endocrine Society's Annual Meeting, ENDO 2023, June 15-18, 2023, Chicago, IL